Zouhayr Souirti
Zouhayr Souirti has a total of 84 co-authors. Here are the top co-authors by number of shared publications:
M.F. Belahsen
Service de neurologie, CHU Hassan II, route Sidi-Harazem, BP 1835, Atlas, Fès, Maroc
6 shared publicationsF. Belahsen
Service de neurologie, CHU Hassan II, 30000 Fès, Maroc
3 shared publicationsSamira El Fakir
3 shared publicationsA. Babakhouya
2 shared publications- Abdelkrim Janati Idrissi
Clinical Neurosciences laboratory, Faculty of medicine and pharmacy of Fez, Sidi Mohamed Ben Abdellah University
2 shared publications M. Boubbou
2 shared publications
Latest Publications
- Open Access
- 26 June 2026
- Published by Partners in Digital Health in Telehealth and Medicine Today
- Vol. 11 (2)
Telemedicine Post-Covid-19 as a Strategic Lever for Transforming Access to Healthcare
Background: The Moroccan health system faces significant structural problems, including major regional disparities in access to primary healthcare, the persistence of “medical deserts” (rural areas in extreme conditions, especially mountainous regions), and a rapidly growing burden of chronic diseases. The physician density (ratio of 7.8 per 10,000 people) is far below the World Health Organization’s minimum recommendation of 23 per 10,000, with a shortage of healthcare workers estimated to exceed 97,000 (1,2).Methods: This study examines the role of telemedicine as a technology-based solution to address these systemic weaknesses. It analyses the structural limitations of the existing healthcare model in Morocco, drawing on public health data and the impact of the COVID-19 outbreak as a catalyst for reform.Results: The findings highlight that telemedicine is now considered an essential component of healthcare delivery. It offers a strategic means of enhancing access to care, particularly in underserved and remote areas, while supporting the development of a more equitable and patient-centered healthcare system.Conclusions: Telemedicine represents a promising and necessary approach to overcoming Morocco’s healthcare challenges. Its structured adoption can help bridge the gap between urban and rural healthcare access, reduce the burden on the existing workforce, and improve patient outcomes across the country
- 26 June 2026
- Published by Partners in Digital Health in Telehealth and Medicine Today
- Vol. 11 (2)
Open AccessTelemedicine Post-Covid-19 as a Strategic Lever for Transforming Access to Healthcare
Background: The Moroccan health system faces significant structural problems, including major regional disparities in access to primary healthcare, the persistence of “medical deserts” (rural areas in extreme conditions, especially mountainous regions), and a rapidly growing burden of chronic diseases. The physician density (ratio of 7.8 per 10,000 people) is far below the World Health Organization’s minimum recommendation of 23 per 10,000, with a shortage of healthcare workers estimated to exceed 97,000 (1,2).Methods: This study examines the role of telemedicine as a technology-based solution to address these systemic weaknesses. It analyses the structural limitations of the existing healthcare model in Morocco, drawing on public health data and the impact of the COVID-19 outbreak as a catalyst for reform.Results: The findings highlight that telemedicine is now considered an essential component of healthcare delivery. It offers a strategic means of enhancing access to care, particularly in underserved and remote areas, while supporting the development of a more equitable and patient-centered healthcare system.Conclusions: Telemedicine represents a promising and necessary approach to overcoming Morocco’s healthcare challenges. Its structured adoption can help bridge the gap between urban and rural healthcare access, reduce the burden on the existing workforce, and improve patient outcomes across the country
- Open Access
- 23 February 2026
- Published by Pan African Medical Journal in Pan African Medical Journal
- Vol. 53, 96
When measles is not benign: meningoencephalitis and status epilepticus in an unvaccinated adolescent (case report)
Measles is a highly contagious viral exanthematous disease, caused by a Morbillivirus, that continues to cause outbreaks in under-immunized populations. While neurologic complications are rare, the progression to meningoencephalitis with convulsive status epilepticus is exceptional, particularly in immunocompetent adolescents. We report a 17-year-old unvaccinated male who presented with a febrile, descending asymptomatic maculopapular rash, lacking Koplik spots, followed by rapid onset of severe headache, photophobia, vomiting, and convulsive status epilepticus. Day-7 IgM was negative, and PCR was unavailable, prompting a broad viral, bacterial, and autoimmune workup, all of which were excluded. Cerebrospinal Fluid (CSF) showed mild protein elevation without pleocytosis, and repeat serology confirmed measles (IgM 1210 IU/mL; IgG 1980 IU/mL). The patient received meningeal-dose ceftriaxone, acyclovir, antiepileptics, and high-dose vitamin A per World Health Organization (WHO) recommendations, with complete neurologic recovery. This case highlights an uncommon but severe neurologic complication of measles in an unvaccinated adolescent, emphasizing the risk of diagnostic delay due to atypical features and early seronegativity. It reinforces the need for high clinical suspicion, broad etiologic evaluation, early empiric therapy, and sustained efforts to ensure complete vaccination.
- 23 February 2026
- Published by Pan African Medical Journal in Pan African Medical Journal
- Vol. 53, 96
Open AccessWhen measles is not benign: meningoencephalitis and status epilepticus in an unvaccinated adolescent (case report)
Measles is a highly contagious viral exanthematous disease, caused by a Morbillivirus, that continues to cause outbreaks in under-immunized populations. While neurologic complications are rare, the progression to meningoencephalitis with convulsive status epilepticus is exceptional, particularly in immunocompetent adolescents. We report a 17-year-old unvaccinated male who presented with a febrile, descending asymptomatic maculopapular rash, lacking Koplik spots, followed by rapid onset of severe headache, photophobia, vomiting, and convulsive status epilepticus. Day-7 IgM was negative, and PCR was unavailable, prompting a broad viral, bacterial, and autoimmune workup, all of which were excluded. Cerebrospinal Fluid (CSF) showed mild protein elevation without pleocytosis, and repeat serology confirmed measles (IgM 1210 IU/mL; IgG 1980 IU/mL). The patient received meningeal-dose ceftriaxone, acyclovir, antiepileptics, and high-dose vitamin A per World Health Organization (WHO) recommendations, with complete neurologic recovery. This case highlights an uncommon but severe neurologic complication of measles in an unvaccinated adolescent, emphasizing the risk of diagnostic delay due to atypical features and early seronegativity. It reinforces the need for high clinical suspicion, broad etiologic evaluation, early empiric therapy, and sustained efforts to ensure complete vaccination.
- 8 April 2024
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 241, 108282
Quality of life predictors among Moroccan adults with epilepsy
- 8 April 2024
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 241, 108282
Quality of life predictors among Moroccan adults with epilepsy
- Open Access
- 8 February 2024
- Published by Elsevier in Sleep Epidemiology
- Vol. 4
Moroccan validation of the dysfunctional beliefs and attitudes about sleep (DBAS-16) scale
- 8 February 2024
- Published by Elsevier in Sleep Epidemiology
- Vol. 4
Open AccessMoroccan validation of the dysfunctional beliefs and attitudes about sleep (DBAS-16) scale
- Open Access
- 21 October 2023
- Published by Wiley in Epilepsia Open
- Vol. 8 (4) , 1340-1349
Prevalence of epilepsy in Morocco: A population‐based study
Objective: In Morocco, there was a lack of data related to the epidemiology of epilepsy. This data serves as a useful basis for the development of any national intervention or action program against epilepsy in Morocco. Through this study, we aimed to estimate the active and lifetime prevalence of epilepsy in Morocco.Methods: We collected data from eight out of 12 Moroccan regions in two steps: In the screening step, we first used a nationwide telephone diagnosis questionnaire and in the second stage, a team of physicians under the direction of an epileptologist conducted a confirmative survey for suspected cases. We fixed the confidence interval at α = 5% and the precision at 0.02.Results: Up to 3184 responded positively to our invitation to participate in this study and were able to answer the questions of the first diagnostic questionnaire. In the diagnostic phase, physicians in neurology reinterviewed all 86 suspected cases using a confirmative diagnosis questionnaire, and 63 persons were confirmed as having lifetime epilepsy and 56 with active epilepsy. The mean age (Mean ± SD) of persons with epilepsy was 35.53 years (±21.36). The prevalence of lifetime and active epilepsy were 19.8 (19.6–20.0) and 17.6 (17.5–17.8) per 1000 (95% confidence interval), respectively.Significance: This is the first study to estimate the active and lifetime prevalence of epilepsy in Morocco according to the international recommendations of the ILAE. The prevalence of lifetime and active epilepsy were 19.8 (15–24.6) and 17.6 (13.3–22.8) per 1000, respectively. We included both children and elderly subjects. The rates of active and lifetime population epilepsy prevalence in Morocco ranged between Asian and sub‐Saharan Africa low‐ and middle‐income countries.
- 21 October 2023
- Published by Wiley in Epilepsia Open
- Vol. 8 (4) , 1340-1349
Open AccessPrevalence of epilepsy in Morocco: A population‐based study
Objective: In Morocco, there was a lack of data related to the epidemiology of epilepsy. This data serves as a useful basis for the development of any national intervention or action program against epilepsy in Morocco. Through this study, we aimed to estimate the active and lifetime prevalence of epilepsy in Morocco.Methods: We collected data from eight out of 12 Moroccan regions in two steps: In the screening step, we first used a nationwide telephone diagnosis questionnaire and in the second stage, a team of physicians under the direction of an epileptologist conducted a confirmative survey for suspected cases. We fixed the confidence interval at α = 5% and the precision at 0.02.Results: Up to 3184 responded positively to our invitation to participate in this study and were able to answer the questions of the first diagnostic questionnaire. In the diagnostic phase, physicians in neurology reinterviewed all 86 suspected cases using a confirmative diagnosis questionnaire, and 63 persons were confirmed as having lifetime epilepsy and 56 with active epilepsy. The mean age (Mean ± SD) of persons with epilepsy was 35.53 years (±21.36). The prevalence of lifetime and active epilepsy were 19.8 (19.6–20.0) and 17.6 (17.5–17.8) per 1000 (95% confidence interval), respectively.Significance: This is the first study to estimate the active and lifetime prevalence of epilepsy in Morocco according to the international recommendations of the ILAE. The prevalence of lifetime and active epilepsy were 19.8 (15–24.6) and 17.6 (13.3–22.8) per 1000, respectively. We included both children and elderly subjects. The rates of active and lifetime population epilepsy prevalence in Morocco ranged between Asian and sub‐Saharan Africa low‐ and middle‐income countries.
- 1 June 2023
- Published by JLE in Cahiers Santé Médecine thérapeutique
- Vol. 33 (3) , 126-129
Incomplete cavernous sinus syndrome with cystic adenoid carcinoma of the palate
- 1 June 2023
- Published by JLE in Cahiers Santé Médecine thérapeutique
- Vol. 33 (3) , 126-129
Incomplete cavernous sinus syndrome with cystic adenoid carcinoma of the palate
- 10 May 2022
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 99, 40-42
The Modern Moroccan Terminology of Epilepsy
- 10 May 2022
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 99, 40-42
The Modern Moroccan Terminology of Epilepsy
- 1 December 2016
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 34, 276-280
Focal drug-resistant epilepsy: Progress in care and barriers, a Morroccan perspective
- 1 December 2016
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 34, 276-280
Focal drug-resistant epilepsy: Progress in care and barriers, a Morroccan perspective
- 1 November 2015
- Published by Elsevier in Revue Neurologique
- Vol. 171 (11) , 802-803
Syndrome auto-immun multiple associé à une neuromyélite optique de Devic séropositive
- 1 November 2015
- Published by Elsevier in Revue Neurologique
- Vol. 171 (11) , 802-803
Syndrome auto-immun multiple associé à une neuromyélite optique de Devic séropositive